A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : KSHV / Kaposi's sarcoma-associated herpesvirus

[Related PubMed/MEDLINE]
Total Number of Papers: 2124
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   KSHV  (>> Co-occurring Abbreviation)
Long Form:   Kaposi's sarcoma-associated herpesvirus
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Rare Case of the Newly Recognized Kaposi Sarcoma Herpesvirus-Associated Disease. HIV, KICS, KS
2020 A Recombinant Rhesus Monkey Rhadinovirus Deleted of Glycoprotein L Establishes Persistent Infection of Rhesus Macaques and Elicits Conventional T Cell Responses. gL, HIV, MHC-I, PBMC, RRV, RRV, SIV
2020 ADAR1 Facilitates KSHV Lytic Reactivation by Modulating the RLR-Dependent Signaling Pathway. ADAR1, RLR
2020 Animal Models for Gammaherpesvirus Infections: Recent Development in the Analysis of Virus-Induced Pathogenesis. EBV, NHPs
2020 Biophysical Screens Identify Fragments That Bind to the Viral DNA-Binding Proteins EBNA1 and LANA. EBNA1, EBV, LANA, SPR, STD
2020 Clinical and pathological features of kaposi sarcoma herpesvirus inflammatory cytokine syndrome: case report and review of the literature. KICS
2020 Comparative analysis of the viral interferon regulatory factors of KSHV for their requisite for virus production and inhibition of the type I interferon pathway. IFN
2020 Complex Interactions between Cohesin and CTCF in Regulation of Kaposi's Sarcoma-Associated Herpesvirus Lytic Transcription. ChIP-seq
2020 Concurrent Control of the Kaposi's Sarcoma-Associated Herpesvirus Life Cycle through Chromatin Modulation and Host Hedgehog Signaling: a New Prospect for the Therapeutic Potential of Lipoxin A4. 5-LO, AhR, AMPK, COX-2, hh, hh, LXA4, MCM, PD-L1, RTA
10  2020 Conserved CxnC Motifs in Kaposi's Sarcoma-Associated Herpesvirus ORF66 Are Required for Viral Late Gene Expression and Are Essential for Its Interaction with ORF34. vTAs
11  2020 Control of Viral Latency by Episome Maintenance Proteins. EBV, EMP, HPV
12  2020 Developing new ceramide analogs and identifying novel sphingolipid controlled genes against a virus-associated lymphoma. PEL
13  2020 Development of cyclic peptide derivatives from the N-terminal region of LANA for targeting the nucleosome acidic patch. KS
14  2020 Discovery of Novel Latency-Associated Nuclear Antigen Inhibitors as Antiviral Agents Against Kaposi's Sarcoma-Associated Herpesvirus. FP, LANA, SPR
15  2020 Distinct genetic architectures and environmental factors associate with host response to the gamma2-herpesvirus infections. EBV, GWAS, HLA
16  2020 EBV gH/gL and KSHV gH/gL bind to different sites on EphA2 to trigger fusion. EBV, EphA2
17  2020 Effects of HIV on the Tumor Microenvironment. ART, PWH, TME
18  2020 Epigenetic control in Kaposi sarcoma-associated herpesvirus infection and associated disease. ---
19  2020 Epigenetic factor siRNA screen during primary KSHV infection identifies novel host restriction factors for the lytic cycle of KSHV. LANA, NuRD, RTA
20  2020 Epigenetic Regulation of Kaposi's Sarcoma-Associated Herpesvirus Latency. lncRNAs, PTM
21  2020 Gammaherpesvirus-infected germinal center cells express a distinct immunoglobulin repertoire. gammaHVs, GC
22  2020 Global epigenomic analysis of KSHV-infected primary effusion lymphoma identifies functional MYC superenhancers and enhancer RNAs. ChIP-seq, eRNAs, GRO-seq, PEL
23  2020 Hit-to-lead optimization of a latency-associated nuclear antigen inhibitor against Kaposi's sarcoma-associated herpesvirus infections. EMSA, FP, LANA
24  2020 HIV-1 Tat Interacts with a Kaposi's Sarcoma-Associated Herpesvirus Reactivation-Upregulated Antiangiogenic Long Noncoding RNA, LINC00313, and Antagonizes Its Function. HIV, HIV-1, IPA, KS, lncRNA, PRC2
25  2020 Human Immunodeficiency Virus-Associated Exosomes Promote Kaposi's Sarcoma-Associated Herpesvirus Infection via the Epidermal Growth Factor Receptor. EGFR, HIV, KS, TAR
26  2020 Induction of Kaposi's Sarcoma-Associated Herpesvirus-Encoded Thymidine Kinase (ORF21) by X-Box Binding Protein 1. KS, MCD, PEL, RTA, TK, vIL-6, XRE
27  2020 Interaction With 14-3-3 Correlates With Inactivation of the RIG-I Signalosome by Herpesvirus Ubiquitin Deconjugases. EBV, HCMV, HSV-1
28  2020 Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma. BCR, IL-10, IL-1beta, IRAK, IRAK4 KOs, KO, MYD88, PEL
29  2020 Kaposi Sarcoma-Associated Herpesvirus (KSHV). ---
30  2020 Kaposi Sarcoma-Associated Herpesvirus and Staphylococcus aureus Coinfection in Oral Cavities of HIV-Positive Patients: A Unique Niche for Oncogenic Virus Lytic Reactivation. HIV, KS, PAMPs
31  2020 Kaposi Sarcoma-Associated Herpesvirus Infection and Endemic Burkitt Lymphoma. eBL, EBV, OR
32  2020 Kaposi's Sarcoma-Associated Herpesvirus and Host Interaction by the Complement System. ---
33  2020 Kaposi's Sarcoma-Associated Herpesvirus Drives a Super-Enhancer-Mediated Survival Gene Expression Program in Primary Effusion Lymphoma. BATF, ChIP-seq, IFN, PEL, SE, TF, vIRF3
34  2020 Kaposi's Sarcoma-Associated Herpesvirus Fine-Tunes the Temporal Expression of Late Genes by Manipulating a Host RNA Quality Control Pathway. NRDE2, PPD
35  2020 Kaposi's Sarcoma-Associated Herpesvirus Infection Induces the Expression of Neuroendocrine Genes in Endothelial Cells. ADM2, HRH1, KO, KS, NE, NSE, ORFK12, PGP 9.5, SSTR1
36  2020 Kaposi's sarcoma-associated herpesvirus is cell-intrinsically controlled in latency in microgravity. ---
37  2020 Kaposi's Sarcoma-Associated Herpesvirus LANA Modulates the Stability of the E3 Ubiquitin Ligase RLIM. LANA
38  2020 Kaposi's Sarcoma-Associated Herpesvirus Lytic Replication Is Independent of Anaphase-Promoting Complex Activity. APC/C, EBV, HCMV, LECs
39  2020 Kaposi's Sarcoma-Associated Herpesvirus ORF66 Is Essential for Late Gene Expression and Virus Production via Interaction with ORF34. BAC, vPIC
40  2020 Kaposi's Sarcoma-Associated Herpesvirus Reactivation by Targeting of a dCas9-Based Transcription Activator to the ORF50 Promoter. CRISPRa, dCas9, DD
41  2020 Kaposi's Sarcoma-Associated Herpesvirus Viral Interleukin-6 Signaling Upregulates Integrin beta3 Levels and Is Dependent on STAT3. hIL-6, ITGB3, siRNA, vIL-6
42  2020 Kaposi's sarcoma-associated herpesvirus viral protein kinase phosphorylates extracellular signal-regulated kinase and activates MAPK/ERK signaling pathway. ORF36, vPK
43  2020 Kaposi's Sarcoma-Associated Herpesvirus-Encoded circRNAs Are Expressed in Infected Tumor Tissues and Are Incorporated into Virions. circRNAs, PAN, PEL, RT-PCR, vIRF4
44  2020 KSHV dysregulates bulk macroautophagy, mitophagy and UPR to promote endothelial to mesenchymal transition and CCL2 release, key events in viral-driven sarcomagenesis. EMT, EndMT, UPR
45  2020 KSHV infection skews macrophage polarisation towards M2-like/TAM and activates Ire1 alpha-XBP1 axis up-regulating pro-tumorigenic cytokine release and PD-L1 expression. ---
46  2020 KSHV ORF59 and PAN RNA Recruit Histone Demethylases to the Viral Chromatin during Lytic Reactivation. PAN RNA, PRMT5
47  2020 KSHV requires vCyclin to overcome replicative senescence in primary human lymphatic endothelial cells. KS, LECs, PEL
48  2020 Lack of CD8+ T-cell co-localization with Kaposi's sarcoma-associated herpesvirus infected cells in Kaposi's sarcoma tumors. ANOVA, EnKS, EpKS, KS, TIIC
49  2020 LANA and hnRNP A1 Regulate the Translation of LANA mRNA through G-Quadruplexes. hnRNP A1, LANA, MHC
50  2020 Lenalidomide in Combination with Arsenic Trioxide: an Effective Therapy for Primary Effusion Lymphoma. ATO, IL-6, Lena, PEL
51  2020 Lymphotropic Viruses EBV, KSHV and HTLV in Latin America: Epidemiology and Associated Malignancies. A Literature-Based Study by the RIAL-CYTED. EBV, HL, LA
52  2020 Molecular analysis of lymphoid tissue from rhesus macaque rhadinovirus-infected monkeys identifies alterations in host genes associated with oncogenesis. AICDA, BAC, CX3CR1, GPC1, LN, LPD, RasD1, RM, RRV, SIV, TXNIP, vCD200
53  2020 Narciclasine, an isocarbostyril alkaloid, has preferential activity against primary effusion lymphoma. PEL
54  2020 New Kaposi's sarcoma-associated herpesvirus variant in men who have sex with men associated with severe pathologies. KS, MCD, PEL, PrEP
55  2020 Oncogenic Herpesvirus Engages Endothelial Transcription Factors SOX18 and PROX1 to Increase Viral Genome Copies and Virus Production. LEC
56  2020 Oncogenic human herpesvirus hijacks proline metabolism for tumorigenesis. P5C, PRODH
57  2020 Outcome markers of ART-treated HIV+ patients with early stage Kaposi's sarcoma. ART, EpKS, IL, NAb
58  2020 p300 promotes cell proliferation through suppressing Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation in the infected B-lymphoma cells. PEL
59  2020 PAN RNA: transcriptional exhaust from a viral engine. eRNA, HHV-8, PEL
60  2020 Pemetrexed inhibits Kaposi's sarcoma-associated herpesvirus replication through blocking dTMP synthesis. ---
61  2020 Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma. PDCN, PR, SD, VL
62  2020 Porphyromonas gingivalis coinfects with KSHV in oral cavities of HIV+ patients and induces viral lytic reactivation. KS
63  2020 PPP6C Negatively Regulates STING-Dependent Innate Immune Responses. cGAS, dsDNA, dsRNA, HSV-1, ORF48, Ppp6c, STING, VSV
64  2020 Prevalence of Kaposi's sarcoma-associated herpesvirus and transfusion-transmissible infections in Tanzanian blood donors. CI, KS, OR
65  2020 Productive herpesvirus lytic replication in primary effusion lymphoma cells requires S-phase entry. DDR
66  2020 R-loop-forming Sequences Analysis in Thousands of Viral Genomes Identify A New Common Element in Herpesviruses. RLFS, TRs
67  2020 Rainbow Kaposi's Sarcoma-Associated Herpesvirus Revealed Heterogenic Replication with Dynamic Gene Expression. ---
68  2020 Regulation of Autophagy in Cells Infected With Oncogenic Human Viruses and Its Impact on Cancer Development. EBV, HBV, HCV, HR-HPVs, HTLV-1, MCPyV
69  2020 Risk Factors for Kaposi's Sarcoma-Associated Herpesvirus DNA in Blood and in Saliva in Rural Uganda. ---
70  2020 RNA decay during gammaherpesvirus infection reduces RNA polymerase II occupancy of host promoters but spares viral promoters. MHV-68, Pol II
71  2020 Role of SUMOylation in Human Oncogenic Herpesvirus Infection. EBV, SUMO
72  2020 Runaway Kaposi Sarcoma-associated herpesvirus replication correlates with systemic IL-10 levels. HIV-1, KICS, KS
73  2020 Signatures of oral microbiome in HIV-infected individuals with oral Kaposi's sarcoma and cell-associated KSHV DNA. KS, OTUs
74  2020 Sp3 Transcription Factor Cooperates with the Kaposi's Sarcoma-Associated Herpesvirus ORF50 Protein To Synergistically Activate Specific Viral and Cellular Gene Promoters. IL-10, ORF50
75  2020 Specific Inhibition of Viral MicroRNAs by Carbon Dots-Mediated Delivery of Locked Nucleic Acids for Therapy of Virus-Induced Cancer. LNA, miRNAs, PEL
76  2020 Sperm associated antigen 9 promotes oncogenic KSHV-encoded interferon regulatory factor-induced cellular transformation and angiogenesis by activating the JNK/VEGFA pathway. CAM, KS, MKK4, SPAG9, vIRF1
77  2020 STING is dispensable during KSHV infection of primary endothelial cells. EC
78  2020 Targeting Kaposi's Sarcoma-Associated Herpesvirus ORF21 Tyrosine Kinase and Viral Lytic Reactivation by Tyrosine Kinase Inhibitors Approved for Clinical Use. ORF, TK
79  2020 The anti-malaria agent artesunate exhibits cytotoxic effects in primary effusion lymphoma. PEL
80  2020 The bZIP Proteins of Oncogenic Viruses. bZIP, EBV, HCV, HTLV, MDV, TFs
81  2020 The Kaposi's Sarcoma-Associated Herpesvirus (KSHV) gH/gL Complex Is the Predominant Neutralizing Antigenic Determinant in KSHV-Infected Individuals. KS, NAbs
82  2020 The Lymphatic Cell Environment Promotes Kaposi Sarcoma Development by Prox1-Enhanced Productive Lytic Replication of Kaposi Sarcoma Herpes Virus. ---
83  2020 The potential impacts of early secreted antigenic target of 6 kDa (ESAT-6) of Mycobacterium tuberculosis on KSHV-infected cells. ESAT-6, KS, Mtb, PEL, TB
84  2020 The RNA quality control pathway nonsense-mediated mRNA decay targets cellular and viral RNAs to restrict KSHV. NMD, PEL
85  2020 The Sub-Nuclear Localization of RNA-Binding Proteins in KSHV-Infected Cells. ---
86  2020 Tocilizumab in patients with symptomatic Kaposi sarcoma herpesvirus-associated multicentric Castleman disease. ---
87  2020 TRANSPIRE: A Computational Pipeline to Elucidate Intracellular Protein Movements from Spatial Proteomics Data Sets. HCMV, LDLR
88  2020 Tumor Microenvironment Conditioning by Abortive Lytic Replication of Oncogenic gamma-Herpesviruses. EBV
89  2020 Two microPeptides are translated from a KSHV polycistronic RNA in human cells by leaky scanning mechanism. ---
90  2020 Update on Kaposi sarcoma-associated herpesvirus (HHV8) - review. ---
91  2020 Variation in KSHV prevalence between geographically proximate locations in Uganda. EMaBS, GHWP, GPC
92  2020 Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi's Sarcoma Patients. HIV-1, KS, NAb, SSA
93  2020 Viral FLIP blocks Caspase-8 driven apoptosis in the gut in vivo. HHV-8, vFLIP
94  2020 Viral interleukin-6 encoded by an oncogenic virus promotes angiogenesis and cellular transformation by enhancing STAT3-mediated epigenetic silencing of caveolin 1. Cav-1, DNMT1, KS, vIL-6
95  2019 A comparative epigenome analysis of gammaherpesviruses suggests cis-acting sequence features as critical mediators of rapid polycomb recruitment. MHV-68, PRC
96  2019 A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. A3A, A3B, EBV, HSV-1, ORF61, RNR
97  2019 A Gammaherpesvirus MicroRNA Targets EWSR1 (Ewing Sarcoma Breakpoint Region 1) In Vivo To Promote Latent Infection of Germinal Center B Cells. EBV, EWSR1, MHV-68, miRNAs
98  2019 A herpesvirus transactivator and cellular POU proteins extensively regulate DNA binding of the host Notch signaling protein RBP-Jkappa to the virus genome. POU
99  2019 A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits. KSHV-LP
100  2019 A role of hypoxia-inducible factor 1 alpha in Murine Gammaherpesvirus 68 (MHV68) lytic replication and reactivation from latency. EBV, gammaHV, HIF-1alpha, HREs, MHV-68, vGPCR